← Back to Search

Behavioral Intervention

Pain Management Class for Pain Catastrophizing

N/A
Waitlist Available
Research Sponsored by Oregon Health and Science University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up participants will be assessed as part of a cohort for up to 7 months. there will be a total of three cohorts.
Awards & highlights

Summary

The primary objective of this study is to examine a single-session, 2-hour group intervention provided to a population of transgender or gender-diverse patients with chronic pain prior to gender-affirming surgery, to determine if participants who receive the intervention have less pain-related distress compared to participants randomly assigned to the control group.

Who is the study for?
This trial is for transgender or gender-diverse individuals with chronic pain lasting more than 3 months and a pain intensity of at least 4 on a scale of 0-10. Participants must be fluent in English, affiliated with the OHSU Transgender Health Program, and have had their initial consultation for gender-affirming surgery.
What is being tested?
The study tests if a single-session group intervention called Empowered Relief can reduce pain-related distress before gender-affirming surgery compared to standard care. Participants are randomly assigned to either the intervention or control group.
What are the potential side effects?
Since this trial involves non-medical interventions (Empowered Relief), typical drug side effects are not expected. However, participants may experience emotional discomfort when discussing personal experiences related to pain.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~participants will be assessed as part of a cohort for up to 7 months. there will be a total of three cohorts.
This trial's timeline: 3 weeks for screening, Varies for treatment, and participants will be assessed as part of a cohort for up to 7 months. there will be a total of three cohorts. for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Pain Catastrophizing

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Pain Management ClassExperimental Treatment1 Intervention
Pain Management Class Prior to Gender Affirming Surgery
Group II: SOC - No ClassActive Control1 Intervention
SOC for Gender Affirming Surgery

Find a Location

Who is running the clinical trial?

Oregon Health and Science UniversityLead Sponsor
994 Previous Clinical Trials
7,387,332 Total Patients Enrolled
~52 spots leftby May 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top